Body Mass Index (BMI) and Quality of Life (QoL) in Cancer Patients

Launched by UNIVERSITY OF ROME TOR VERGATA · Mar 11, 2019

Keywords

ClinConnect Summary

This clinical trial is studying how Body Mass Index (BMI), which is a measure of body weight in relation to height, affects the quality of life in cancer patients. Researchers want to understand whether being underweight or overweight impacts how patients feel and function during their cancer treatment. They will be using a specific questionnaire called the EORTC-QLQ-C30 to gather information from patients about their quality of life. This study aims to include various types of cancer patients, such as those with localized tumors versus those with metastatic (spread) disease.

To participate in this trial, you need to be at least 18 years old and have a confirmed diagnosis of a solid tumor (like breast, lung, or colon cancer). You also need to be expected to live for at least 12 weeks and be able to provide consent to join the study. Unfortunately, if you have other cancers or cannot complete the questionnaire, you won't be eligible. If you choose to participate, you can expect to share your experiences and feelings about your health, which may help improve understanding of how weight affects cancer patients' lives.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Histologically confirmed diagnosis of solid tumor
• • 2. Age \>18 years
• • 3. Signed informed consent
• • 4. Life expectancy \> 12 weeks
• Exclusion Criteria:
• • 1. Inability to fill out the EORTC QLQ-C30 questionnaire.
• • 2. Absence of a certain diagnosis of solid tumor (e.g. subjects on screening programs)
• • 3. Diagnosis of second malignancies that might bias results interpretation